#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alagille syndrome Ataxia telangiectasia Red blood cell abnormality Ewing's sarcoma metastatic Lennox-Gastaut syndrome Retinal artery occlusion Hormone-dependent prostate cancer Acromegaly Paraganglion neoplasm Alexander disease Non-small cell lung cancer recurrent Nodal marginal zone B-cell lymphoma Basal cell naevus syndrome Allogenic stem cell transplantation Mitochondrial DNA depletion More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Treatment Mucopolysaccharidosis I – Basic Information Erdheim-Chester disease – Treatment Antithrombin III deficiency – Trials in Disease Mantle cell lymphoma – Trials in Disease Chordoma – Basic Information Congenital generalised lipodystrophy – Diagnostics Small intestine leiomyosarcoma – Diagnostics Gastrointestinal stromal tumour – Life with Disease Systemic mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ADCE-D01 Eculizumab Ravulizumab BRENSOCATIB Zinc Acetate Dihydrate Garadacimab Juniper Berry Oil Human Vaccinia Immunoglobulin Alisertib Sodium Tramadol Hydrochloride Mycophenolate Sodium ZILEBESIRAN Navitoclax Vx-522 Repotrectinib Pyrimethamine 20-HYDROXYECDYSONE Zofenopril Calcium Cisatracurium Besilate Raludotatug Deruxtecan More therapies…

    Learn about Your Condition

    Biliary tract operation Univentricular heart Lung cancer metastatic Castleman's disease Asthmatic crisis Adrenocortical carcinoma Immunodeficiency congenital Malignant oligodendroglioma Basal cell carcinoma Crigler-Najjar syndrome Genitourinary tract neoplasm Retroperitoneal cancer Arteriosclerosis Intellectual disability Interstitial lung disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac arrest

  • Study on Levosimendan for Improving Survival in Patients with Out-of-Hospital Cardiac Arrest During CPR

    Recruiting

    2 1 1
    Investigated Drugs:
    • Levosimendan
    Sweden

  • Study of anti-seizure drug combination in comatose patients with status epilepticus after cardiac arrest

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lacosamide
    • Lorazepam
    • Diazepam
    Belgium The Netherlands

  • Study on the Use of Epinephrine for Newborns with Cardiac Arrest at Birth

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Epinephrine
    France

  • Study on the Effect of Landiolol Hydrochloride and Sodium Chloride in Patients Experiencing Cardiac Arrest

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ventricular fibrillation
    • Cardiac arrest
    Investigated Drugs:
    • Landiolol Hydrochloride
    • Sodium Chloride
    Austria

  • Study on the Effects of Sodium Lactate and Electrolyte Solution in Comatose Patients After Cardiac Arrest

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    • Post cardiac arrest syndrome
    • Reperfusion injury
    Investigated Drugs:
    • Sodium Lactate
    • Magnesium Chloride Hexahydrate
    • Potassium Chloride
    Belgium

  • Study on the Effects of Esketamine Hydrochloride and Propofol for Patients After Cardiac Arrest

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Propofol
    Denmark
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!